Triple

T513554
Position Surface form Disambiguated ID Type / Status
Subject Duke Human Vaccine Institute E10656 entity
Predicate collaboratesWith P37 FINISHED
Object HIV Vaccine Trials Network
The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
E63970 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: HIV Vaccine Trials Network | Statement: [Duke Human Vaccine Institute, collaboratesWith, HIV Vaccine Trials Network]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: HIV Vaccine Trials Network
Context triple: [Duke Human Vaccine Institute, collaboratesWith, HIV Vaccine Trials Network]
  • A. Global Fund to Fight AIDS, Tuberculosis and Malaria
    The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing organization that mobilizes and invests resources to accelerate the end of these three major infectious diseases worldwide.
  • B. UNAIDS
    UNAIDS is the Joint United Nations Programme on HIV/AIDS, leading and coordinating global efforts to prevent HIV infection, expand treatment, and support people living with HIV.
  • C. National Institute of Allergy and Infectious Diseases
    The National Institute of Allergy and Infectious Diseases is a U.S. federal biomedical research agency that leads research and policy on infectious, immunologic, and allergic diseases.
  • D. Office of National AIDS Policy
    The Office of National AIDS Policy is a White House office responsible for coordinating the U.S. federal government’s efforts to prevent and treat HIV/AIDS and develop related national strategies.
  • E. Center for Biostatistics in AIDS Research
    The Center for Biostatistics in AIDS Research is a Harvard-based research center that develops and applies advanced statistical methods to improve the design, analysis, and interpretation of HIV/AIDS clinical and epidemiological studies.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: HIV Vaccine Trials Network
Triple: [Duke Human Vaccine Institute, collaboratesWith, HIV Vaccine Trials Network]
Generated description
The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: HIV Vaccine Trials Network
Target entity description: The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
  • A. Global Fund to Fight AIDS, Tuberculosis and Malaria
    The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing organization that mobilizes and invests resources to accelerate the end of these three major infectious diseases worldwide.
  • B. UNAIDS
    UNAIDS is the Joint United Nations Programme on HIV/AIDS, leading and coordinating global efforts to prevent HIV infection, expand treatment, and support people living with HIV.
  • C. National Institute of Allergy and Infectious Diseases
    The National Institute of Allergy and Infectious Diseases is a U.S. federal biomedical research agency that leads research and policy on infectious, immunologic, and allergic diseases.
  • D. Office of National AIDS Policy
    The Office of National AIDS Policy is a White House office responsible for coordinating the U.S. federal government’s efforts to prevent and treat HIV/AIDS and develop related national strategies.
  • E. Center for Biostatistics in AIDS Research
    The Center for Biostatistics in AIDS Research is a Harvard-based research center that develops and applies advanced statistical methods to improve the design, analysis, and interpretation of HIV/AIDS clinical and epidemiological studies.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2e84a0d08819087e01863fcd9abf1 completed Feb. 28, 2026, 1:06 p.m.
NER Named-entity recognition batch_69a2f1804e908190a1d34ac952e84a3f completed Feb. 28, 2026, 1:45 p.m.
NED1 Entity disambiguation (via context triple) batch_69a4a14f9cc88190ada7a80d5f8ec6fc completed March 1, 2026, 8:27 p.m.
NEDg Description generation batch_69a4a1c63d34819085387882bbc67041 completed March 1, 2026, 8:29 p.m.
NED2 Entity disambiguation (via description) batch_69a4a223c5ec8190a239d548e8c68960 completed March 1, 2026, 8:31 p.m.
Created at: Feb. 28, 2026, 1:12 p.m.